Marketers of Dietary Supplement Amberen Settle FTC Charges Regarding Misleading Weight-Loss and Menopause Relief Claims
Date
Lunada Biomedical, Inc. and its three principals have settled Federal Trade Commission charges that they deceptively marketed Amberen, a dietary supplement, to women over 40 who are perimenopausal or...